Leslie L. Iversen, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 60,000 shares at $22.92 ($1.4M) on 2013-09-12, disclosed to the SEC on 2013-09-13.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2014-01-03 | $1.5M | — | Filing → |
| ACAD | BUY | 2009-05-20 | $5K | — | Filing → |